An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers
Presently, different types of eye diseases, such as glaucoma, myopia, infection, and dry eyes
are treated with topical eye drops. However, due to ocular surface barriers, eye drops …
are treated with topical eye drops. However, due to ocular surface barriers, eye drops …
[HTML][HTML] Up-to-date molecular medicine strategies for management of ocular surface neovascularization
Ocular surface neovascularization and its resulting pathological changes significantly alter
corneal refraction and obstruct light path to the retina, and hence is a major cause of vision …
corneal refraction and obstruct light path to the retina, and hence is a major cause of vision …
Trimethylated chitosan-coated flexible liposomes with resveratrol for topical drug delivery to reduce blue-light-induced retinal damage
H Gu, P Chen, X Liu, Y Lian, J Xi, J Li, J Song… - International Journal of …, 2023 - Elsevier
LED-related blue-light-induced damage can cause eye diseases. However, drug delivery in
patients with ocular diseases is faced with various challenges. In this study, we developed …
patients with ocular diseases is faced with various challenges. In this study, we developed …
Nanoceria-Mediated Cyclosporin A Delivery for Dry Eye Disease Management through Modulating Immune–Epithelial Crosstalk
W Cui, S Chen, T Hu, T Zhou, C Qiu, L Jiang… - ACS …, 2024 - ACS Publications
Dry eye disease (DED) affects a substantial worldwide population with increasing frequency.
Current single-targeting DED management is severely hindered by the existence of an …
Current single-targeting DED management is severely hindered by the existence of an …
[HTML][HTML] Light-responsive polymeric nanoparticles for retinal drug delivery: design cues, challenges and future perspectives
L Guidi, MG Cascone, E Rosellini - Heliyon, 2024 - cell.com
A multitude of sight-threatening retinal diseases, affecting hundreds of millions around the
globe, lack effective pharmacological treatments due to ocular barriers and common drug …
globe, lack effective pharmacological treatments due to ocular barriers and common drug …